Prostate cancer trials in Italy
119 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 12 November 2026. Ask the study team whether a trial fits you.
- No phaseNot yet taking people in ItalyImplementation Of A Telesurgery Program At A Referral Center For Robotic Surgery
- Where
- Roma, Rome
- Age
- 18 years and over
- People
- 25
- Run by
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS
See details and how to joinNCT07792109 - No phaseTaking peopleFocal Micro-boost Strategy in Patients With Intermediate- to High-risk Prostate Cancer (IR-HR PCa) Undergoing Hypofractionated Radiotherapy
- Where
- Rome
- Age
- 18 years to 99 years
- People
- 82
- Run by
- Regina Elena Cancer Institute
See details and how to joinNCT07792993 - Phase 1/2Taking peopleA Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
- Where
- Bologna, Milan, Rome, Rozzano
- Age
- 18 years and over
- People
- 300 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT04104776 · EU 2023-508002-20-00 - Phase 3Taking peopleLow-Intensity Extracorporeal Shockwave Therapy on Penile Rehabilitation After Robot-assisted Surgical Treatment of Genitourinary Cancers
- Where
- Naples, Rome
- Age
- 18 years to 75 years
- People
- 158
- Run by
- Regina Elena Cancer Institute
See details and how to joinNCT06717711 - No phaseTaking peopleNerve-SPARing Robotic Prostatectomy: The Impact of Patient Baseline Profiles on Erectile Function
- Where
- Florence
- Age
- 18 years to 75 years
- People
- 300
- Run by
- University of Florence
See details and how to joinNCT07747272 - No phaseTaking peoplePhoton-Counting Computed Tomography-Based Urethral Visualization Without Catheterization for Radiotherapy Planning: A Prospective Pilot Study Under ANTHEM
- Where
- Rozzano
- Age
- 18 years and over
- People
- 20
- Run by
- Istituto Clinico Humanitas
See details and how to joinNCT07730203 - Phase 2Taking peopleREDI-CaP(Recovery of Erectile Dysfunction Induced in Prostate Cancer Patients)
- Where
- Naples
- Age
- 18 years and over
- People
- 50
- Run by
- National Cancer Institute, Naples
See details and how to joinNCT07302451 · EU 2025-521170-33-00 - Phase 2Taking peopleSbrt±sTad for Unfavorable iNtermediate rIsk/high-risk prostate cancer (STUNNIN): A Randomized Phase II Study
- Where
- Milan, Rome, Trieste
- Age
- 18 years and over
- People
- 146
- Run by
- I.F.O. Istituti Fisioterapici Ospitalieri
See details and how to join2024-511886-12-00 - Phase 1Taking peopleFirst-in-human Study of 225Ac-PSMA-Trillium (BAY 3563254) in Participants With Advanced Metastatic Castration-resistant Prostate Cancer (mCRPC)
- Where
- Milan, Naples
- Age
- 18 years and over
- People
- 198 worldwide
- Run by
- Bayer
See details and how to joinNCT06217822 · EU 2023-507486-26-00 - Phase 2Taking peopleA Long-term Treatment Extension Study of Niraparib in Participants Who Completed a Prior GlaxoSmithKline/TESARO-sponsored Niraparib Study
- Where
- Cremona
- Age
- 18 years and over
- People
- 37 worldwide
- Run by
- GlaxoSmithKline
See details and how to joinNCT04641247 · EU 2023-506618-29-00 - Phase 3Taking peoplePhase III Randomized International Open Label Clinical Trial of Treatment Intensification With Docetaxel Plus Apalutamide in Patients With Metastatic Hormone-sensitive Prostate Cancer Who Did Not Achieve a Deep PSA Response After Initial Treatment With Apalutamide: REINFORCE Trial.
- Where
- Catania, Foggia, Genoa, Macerata, Milan, Modena, Naples, Orbassano, Padova, Palermo, Pisa, Rome, Vicenza
- Age
- 18 years and over
- People
- 320 worldwide
- Run by
- Alianza multidisciplinar para la investigación de los tumores genitourinarios -GUARD
See details and how to joinNCT07333066 · EU 2025-524408-30-01 - Phase 2Not yet taking people in ItalyUltra-hypofractionated radiotHErapy and concomitant oral RelugOlix for treatment of intermediate risk prostate cancer. (Ultra-HERO trial)
- Where
- Aviano, Bergamo, Florence, Messina, Modena, Negrar, Palermo, Parma, Reggio Emilia, Rome, Rozzano, Turin
- Age
- 18 years and over
- People
- 73
- Run by
- Fondazione Radioterapia Oncologica Onlus
See details and how to join2024-518388-37-00 - Phase 4Taking peopleLong-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer
- Where
- Genoa, Milan, Naples, Rome
- Age
- 18 years to 100 years
- People
- 700 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT05803941 · EU 2023-503208-94-00 - No phaseTaking peopleBilateral Versus Unilateral Lymph Node Dissection in High-Risk Prostate Cancer (BALANCE)
- Where
- Bologna, Florence, Foggia, Genova, Milan, Modena, Naples, Roma, Rozzano, Torino, Verona
- Age
- 18 years and over
- People
- 820
- Run by
- University of Turin, Italy
See details and how to joinNCT07580196 - Phase 3Taking peopleTrial of Acetylsalicylic Acid and Atorvastatin in Patients With Castrate-resistant Prostate Cancer
- Where
- Milan
- Age
- 18 years and over
- People
- 1,210 worldwide
- Run by
- Gustave Roussy, Cancer Campus, Grand Paris
See details and how to joinNCT03819101 · EU 2023-508072-11-00 - Phase 3Taking peopleADT +/- Darolutamide in de Novo Metastatic Prostate Cancer Patients With Vulnerable Functional Ability (PEACE6-Vulnerable)
- Where
- Augusta, Avola, Candiolo, Cesena, Foggia, Forlì-FC, Meldola, Milan, Naples, Rome, Rozzano, Siracusa, Trento
- Age
- 18 years and over
- People
- 300 worldwide
- Run by
- UNICANCER
See details and how to joinNCT04916613 · EU 2022-502425-18-00 - Phase 2Taking peopleFully Hybrid 18F-PSMA PET/MRI as One-stop Approach for the Diagnosis of Clinically Significant Prostate Cancer.
- Where
- Milan
- Age
- 18 years and over
- People
- 167
- Run by
- IRCCS San Raffaele
See details and how to joinNCT06305390 - No phaseTaking peopleThe MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study
- Where
- Brescia, Negrar
- Age
- 18 years and over
- People
- 8,000 worldwide
- Run by
- UMC Utrecht
See details and how to joinNCT04075305 - No phaseEnrolling by invitationProstate Cancer Screening: a Pilot Study
- Where
- Candiolo
- Age
- 55 years to 65 years
- People
- 4,500
- Run by
- Fondazione del Piemonte per l'Oncologia
See details and how to joinNCT06238661 - No phaseTaking peoplePSMA PET for Treatment Response evaLuation of systemIC Therapies in prostAte caNcer (PELICAN)
- Where
- Bologna, Cuneo, Genova, Messina
- Age
- 18 years and over
- People
- 1,300
- Run by
- IRCCS Azienda Ospedaliero-Universitaria di Bologna
See details and how to joinNCT07089550 - No phaseTaking peopleABlative Radiotherapy (for) Unfavorable Prostate Tumors 2.0
- Where
- Monza
- Age
- 18 years to 90 years
- People
- 58
- Run by
- University of Milano Bicocca
See details and how to joinNCT07407608 - No phaseTaking peopleSalvage Ultrahypofractionated Postoperative External Radiotherapy For Biochemical Recurrence
- Where
- Monza
- Age
- 18 years to 90 years
- People
- 50
- Run by
- University of Milano Bicocca
See details and how to joinNCT06941363 - No phaseTaking peopleProstate Cancer REsearch Using Cross-validation of Innovative Sampling, Integrating LC-MS/MS for Optimized Therapeutic Drug moNitoring
- Where
- Aviano
- Age
- 18 years and over
- People
- 100
- Run by
- Centro di Riferimento Oncologico - Aviano
See details and how to joinNCT07344363 - Phase 4Taking peopleEffect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years
- Where
- Milan, Roma, Siena, Trieste, Verona
- Age
- 18 years to 64 years
- People
- 2,076 worldwide
- Run by
- Guerbet
See details and how to joinNCT04373564 - No phaseTaking peopleDelayed Pelvic Imaging With [68]Ga-PSMA PET/CT in a Patient With High-risk Prostate Cancer.
- Where
- Bologna
- Age
- 30 years and over
- People
- 244
- Run by
- IRCCS Azienda Ospedaliero-Universitaria di Bologna
See details and how to joinNCT07357259